vimarsana.com
Home
Live Updates
Study Suggests Most Patients with Acute Coronary Syndromes C
Study Suggests Most Patients with Acute Coronary Syndromes C
Study Suggests Most Patients with Acute Coronary Syndromes Can Safely Stop Aspirin One Month After Percutaneous Coronary Intervention
Ticagrelor alone outperforms 12-month DAPT for reducing bleeding with no increased risk
Related Keywords
China ,
Minnesota ,
United States ,
New York ,
Kunshan ,
Fujian ,
Chinese ,
,
Medtronic Corp ,
Icahn School Of Medicine At Mount Sinai ,
Yung Shin Pharmaceutical Industrial Co ,
Chinese Society Of Cardiology ,
Shenzhen Salubris Pharmaceuticals Co Ltd ,
National Natural Scientific Foundation Of China ,
American College Of Cardiology Annual Scientific Session ,
American College ,
Annual Scientific ,
Gregg Stone ,
Icahn School ,
Mount Sinai ,
Chinese Society ,
National Natural Scientific Foundation ,
Jiangsu Provincial ,
Nanjing Municipal Clinical Trial ,
Microport Medical ,
Yung Shin Pharmaceutical Industrial ,